Infineon blocks Innoscience GaN products from US market after patent win

Infineon’s ITC victory isn’t just a patent win—it’s a strategic blockade that reshapes GaN’s global value chain. Technically, the ban forces OEMs reliant on Innoscience’s low-cost GaN dies to redesign power modules, inflating BOM costs by 5–15%. Compliance overhead surges as firms must now audit entire GaN supply stacks for IP contamination, especially concerning Chinese epitaxial wafers. Competitors like Navitas and GaN Systems will opportunistically target vacated mid-tier segments, but lack Innoscience’s cost aggression. Over the next 12–24 months, expect accelerated 'de-risking' from Chinese GaN across non-U.S. markets too—designers will favor European or Japanese substrates paired with integrated IDM models to avoid secondary sanctions. Without robust cross-licensing or foundational IP, Chinese GaN players risk permanent exclusion from premium applications, confined to domestic and price-sensitive emerging economies.